Hietanen E, Malaveille C, Friedman F K, Park S S, Béréziat J C, Brun G, Bartsch H, Gelboin H V
Cancer Res. 1986 Feb;46(2):524-31.
Monoclonal antibodies (MAb 1-7-1 and Mab 2-66-3) specific for cytochrome P-450 (cyt. P-450) isozymes inhibited the metabolism of carcinogens, other xenobiotics, and endogenous compounds in two strains of mice. Postmitochondrial liver supernatant (S9) was prepared from untreated, 3-methylcholanthrene-treated, phenobarbital-treated, and pregnenolone 16 alpha-carbonitrile-treated C57BL/6 (B6) and DBA/2 (D2) mice. The modifying effect of two types of MAb to a 3-methylcholanthrene-induced cyt. P-450 and a phenobarbital-induced cyt. P-450 was investigated for: (a) S9-mediated mutagenicity of aflatoxin B1, benzo(a)pyrene 7,8-dihydrodiol, 2-acetylaminofluorene, and N-nitrosomorpholine in Salmonella typhimurium strains; and (b) the activity of aryl hydrocarbon hydroxylase, ethoxycoumarin O-deethylase, ethoxyresorufin O-deethylase, aminopyrine N-demethylase, and testosterone 6 beta-, 7 alpha-, and 16 beta-hydroxylases. With certain S9s, MAb-1-7-1 inhibited only those cytochrome P-450 isozymes involved predominantly in activity of aryl hydrocarbon hydroxylase, ethoxyresorufin O-deethylase, and ethoxycoumarin O-deethylase and mutagenicity of 2-acetylaminofluorene and benzo(a)pyrene 7,8-dihydrodiol; MAb 2-66-3 inhibited only those involved in aminopyrine N-demethylase and testosterone 6 beta-, 7 alpha, and 16 beta-hydroxylase activity and aflatoxin B1 mutagenicity. Both Mab 1-7-1 and MAb 2-66-3 inhibited cytochrome P-450 isozyme(s) implicated predominantly in testosterone 7 alpha-hydroxylation in S9 from pregnenolone 16 alpha-carbonitrile-treated B6 mice. MAb 1-7-1 did not inhibit N-nitrosomorpholine mutagenicity and MAb 2-66-3 increased it by 2- to 6-fold depending on the source of S9. Using these MAbs, it is thus possible to identify the contribution of the epitope-defined single or class of cyt. P-450 to specific metabolic reactions in S9 from untreated and inducer-treated mice.
针对细胞色素P-450(细胞色素P-450)同工酶的单克隆抗体(MAb 1-7-1和Mab 2-66-3)在两种小鼠品系中抑制了致癌物、其他外源性物质和内源性化合物的代谢。从未经处理、经3-甲基胆蒽处理、经苯巴比妥处理以及经孕烯醇酮16α-腈处理的C57BL/6(B6)和DBA/2(D2)小鼠制备线粒体后肝上清液(S9)。研究了两种单克隆抗体对3-甲基胆蒽诱导的细胞色素P-450和苯巴比妥诱导的细胞色素P-450的修饰作用,包括:(a)S9介导的黄曲霉毒素B1、苯并(a)芘7,8-二氢二醇、2-乙酰氨基芴和N-亚硝基吗啉在鼠伤寒沙门氏菌菌株中的致突变性;以及(b)芳烃羟化酶、乙氧香豆素O-脱乙基酶、乙氧试卤灵O-脱乙基酶、氨基比林N-脱甲基酶和睾酮6β-、7α-和16β-羟化酶的活性。对于某些S9,MAb-1-7-1仅抑制那些主要参与芳烃羟化酶、乙氧试卤灵O-脱乙基酶和乙氧香豆素O-脱乙基酶活性以及2-乙酰氨基芴和苯并(a)芘7,8-二氢二醇致突变性的细胞色素P-450同工酶;MAb 2-66-3仅抑制那些参与氨基比林N-脱甲基酶和睾酮6β-、7α-和16β-羟化酶活性以及黄曲霉毒素B1致突变性的同工酶。MAb 1-7-1和MAb 2-66-3均抑制了孕烯醇酮16α-腈处理的B6小鼠S9中主要参与睾酮7α-羟化的细胞色素P-450同工酶。MAb 1-7-1不抑制N-亚硝基吗啉的致突变性,而MAb 2-66-3根据S9的来源使其增加2至6倍。因此,使用这些单克隆抗体可以确定表位定义的单个或一类细胞色素P-450对未经处理和诱导剂处理的小鼠S9中特定代谢反应的贡献。